Company Overview and News

0
Nikkei up as exporter gains offset weakness in machinery stocks

2018-07-17 thehindubusinessline
Japan's Nikkei share average rose to hover at 3-1/2-week highs on Tuesday as a weak yen lifted exporters, offsetting weakness in machinery stocks hurt by weak Chinese economic data.
6506 TM CPLLF 7203 YASKY TYT TOYOF YASKF

0
Yaskawa Electric Corp. ADR 2018 Q1 - Results - Earnings Call Slides

2018-07-13 seekingalpha
The following slide deck was published by Yaskawa Electric Corp. ADR in conjunction with their 2018 Q1 earnings call.
6506 YASKY YASKF

0
Yaskawa Electric's Earnings Report Underlines The Uncertainties In Automation

2018-07-13 seekingalpha
Yaskawa's reported earnings were good, with nearly 20% revenue growth and 30% operating earnings growth on healthy demand for both motion control and robotics products.
6506 FANUY CGNX YASKY YASKF

0
Nikkei posts best weekly gain since March

2018-07-13 thehindubusinessline
Japan's Nikkei surged to three-week highs on Friday, helped by a weaker yen and gains from index-heavy stock Fast Retailing after it jumped on the back of strong third-quarter results. Tech shares also attracted buyers after tracking strength in their US counterparts, which sent the Nasdaq index to a record high.
6506 KYO ADTTF YASKY 9984 SFTBF ATEYY SFTBY YASKF

0
Tokyo stocks soar on weak yen and Wall Street gains

2018-07-13 japantimes.co.jp
Stocks jumped on the Tokyo Stock Exchange Friday, backed by the yen’s fall against the dollar and an overnight rise in U.S. equities.
6506 YASKY 9984 SFTBF 8035 TOELF 7186 SFTBY YASKF CRDIY TOELY

0
Nikkei posts best weekly gain since March; Fast Retailing jumps

2018-07-13 reuters
TOKYO, July 13 (Reuters) - Japan’s Nikkei surged to three-week highs on Friday, helped by a weaker yen and gains from index-heavy stock Fast Retailing after it jumped on the back of strong third-quarter results.
6506 KYO ADTTF YASKY 9984 SFTBF ATEYY SFTBY YASKF

0
Nikkei rises to 2-1/2-week high; Fast Retailing jumps

2018-07-13 reuters
TOKYO, July 13 (Reuters) - Japan’s Nikkei surged to 2-1/2-week highs on Friday, helped by a weaker yen and gains from index-heavy stock Fast Retailing after it jumped on the back of strong third-quarter results.
6506 ADTTF TTDKF YASKY 9984 SFTBF ATEYY SFTBY YASKF

0
Tokyo stocks turn higher on weaker yen

2018-06-29 japantimes.co.jp
Stocks bounced back on the Tokyo Stock Exchange Friday, lifted by the yen’s weakening against the euro and the dollar.
6506 YASKY YASKF

57
Analyzing The ROBO Global Robotics And Automation ETF

2018-06-23 seekingalpha
The analysis of each ETF holding is done using free cash flow as the primary determinant of value.
HLX CGNX IRBT YASKY ISRG ZBRA NOVT 6506 VALU IPGP 6324 BRKS OII ROK MZOR YASKF

57
Analyzing The ROBO Global Robotics & Automation ETF

2018-06-22 seekingalpha
The analysis of each ETF holding is done using free cash flow as the primary determinant of value.
HLX CGNX IRBT YASKY ISRG ZBRA NOVT 6506 VALU IPGP 6324 BRKS OII ROK MZOR YASKF

0
Schneider Has Put The Pieces In Place To Drive Higher-Value Growth

2018-06-19 seekingalpha
Like Siemens and Rockwell, Schneider is well-positioned for the growing convergence of hardware and software in automation, as well as the deployment of IIoT.
6506 SIEGY SU YASKY AVVYY YASKF

0
Tokyo stocks turn down on U.S.-China trade jitters and Osaka earthquake

2018-06-18 japantimes.co.jp
Stocks turned lower on the Tokyo Stock Exchange on Monday, battered chiefly by concerns over a U.S.-China trade war.
6506 YASKY YASKF

1
Nikkei drops as trade tensions escalate, Osaka quake hits utility stocks

2018-06-18 reuters
TOKYO (Reuters) - Japanese stocks fell on Monday morning as an escalating trade dispute between the United States and China stoked concerns about the impact on global demand, triggering a sell-off in stocks such as makers of construction equipment.
6506 KMTUF 5711 MIMTF YASKY YASKF

1
Nikkei drops as trade tensions escalate, Osaka quake hits utility stocks

2018-06-18 malaymail
TOKYO, June 18 — Japanese stocks fell today morning as an escalating trade dispute between the United States and China stoked concerns about the impact on global demand, triggering a sell-off in stocks such as makers of construction equipment.
6506 KMTUF 5711 MIMTF YASKY YASKF

0
Don’t Rage Against the Machine, or Fanuc - Bloomberg

2018-05-01 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
6506 YASKY YASKF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...